The STING in Non-Alcoholic Fatty Liver Diseases: Potential Therapeutic Targets in Inflammation-Carcinogenesis Pathway
Non-alcoholic fatty liver disease (NAFLD), an important chronic disease, is one of the major causes of high mortality and creates a substantial financial burden worldwide. The various immune cells in the liver, including macrophages, NK cells, dendritic cells, and the neutrophils involved in the inn...
Saved in:
Main Authors: | Juan Lv (Author), Chunlei Xing (Author), Yuhong Chen (Author), Huihui Bian (Author), Nanning Lv (Author), Zhibin Wang (Author), Mingming Liu (Author), Li Su (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An Acid-Sensitive Bone Targeting Delivery System Carrying Acacetin Prevents Osteoporosis in Ovariectomized Mice
by: Xiaochen Sun, et al.
Published: (2022) -
NON-ALCOHOLIC FATTY LIVER DISEASE IN CHILDREN
by: L.V. Chistova, et al.
Published: (2010) -
NON-ALCOHOLIC FATTY LIVER DISEASE IN CHILDREN
by: L.V. Chistova, et al.
Published: (2010) -
ALDH2 mitigates LPS-induced cardiac dysfunction, inflammation, and apoptosis through the cGAS/STING pathway
by: Haoran Liu, et al.
Published: (2023) -
Pentagalloylglucose alleviates acetaminophen-induced acute liver injury by modulating inflammation via cGAS-STING pathway
by: Congyang Zheng, et al.
Published: (2024)